Botswana: MRI incorrectly assumes charges cleared, says Competition Authority
A miscommunication between MRI Botswana and the Competition Authority may have lead to a premature celebration by the emergency medical care company. According to reports, MRI misinterpreted the Competition Authority’s decision to no longer investigate MRI for alleged abuse of dominance practices as a ruling that the Competition Authority did not find MRI guilty of antitrust violations; the Competition Authority, however, says it did not make a ruling and that the issue may still be referred to the Competition Commission. The Competition Authority said in a statement that the decision to end the investigation was made after the Authority did, in fact, find exclusive dealing within MRI, but that it followed an open tender process.
Featured News
DOJ Official Highlights Role of Antitrust and Intellectual Property in Driving US Innovation
Mar 26, 2026 by
CPI
US Judge Dismisses X Lawsuit Alleging Advertising Boycott
Mar 26, 2026 by
CPI
Congress Passes Bill to Unfreeze Billions in Small Business R&D Funding
Mar 26, 2026 by
CPI
EU Charges Major Adult Platforms Over Child Safety Failures Under Digital Services Act
Mar 26, 2026 by
CPI
European Regulators Target Snapchat Over Alleged Safety Failures
Mar 26, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Competitor Collaborations
Mar 26, 2026 by
CPI
Between Scylla and Charybdis – Navigating Transatlantic Antitrust Currents
Mar 26, 2026 by
Tilman Kuhn & Niklas Brüggemann
Cartel Enforcement Moves Into the Labor Market: Trends and Implications
Mar 26, 2026 by
Andreas Kafetzopoulos & Caroline Janssens
Rethinking Buy-Side Antitrust “Group Boycotts”
Mar 26, 2026 by
Craig Falls & Brendan McGuire
Positive Collaborations: The Tools Available to Competition Authorities to Encourage Beneficial Interactions Between Competitors
Mar 26, 2026 by
Rona Bar-Isaac & Thomas Withers